Influx Healthtech Limited (Influx Healthtech Limited)
📈 Influx Healthtech IPO is a book-built issue of ₹58.57 Cr, comprising a fresh issue of 50 lakh shares worth ₹48.00 Cr and an Offer for Sale (OFS) of 11 lakh shares aggregating ₹10.56 Cr.
📈 Grey Market Premium (GMP)
IPO Details & Subscription
IPO Timeline
Influx Healthtech IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | 115200 |
| Retail (Max) | 1 | 1200 | 115200 |
| HNI (Min) | 2 | 2400 | 230400 |
Influx Healthtech IPO Reservation
Here's how the IPO shares are allocated across investor categories:
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Isssue |
Influx Healthtech Limited
Financial Information (Restated)
| Financial Metric | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 70.30 | 41.10 | 28.30 |
| Revenue | 104.99 | 100.10 | 76.07 |
| Profit After Tax | 13.37 | 11.22 | 7.20 |
| Net Worth | 36.15 | 22.87 | 11.65 |
| Reserves and Surplus | 18.00 | 22.85 | 11.63 |
| Total Borrowing | 0.22 | 0.32 | 0.80 |
Key Performance Indicator (KPI)
The estimated market capitalization of Influx Healthtech IPO stands at ₹222.24 crore.
| KPI | Value |
|---|---|
| ROE | 36.98% |
| ROCE | 49.17% |
| Debt/Equity | 0.01 |
| RoNW | 36.98% |
| PAT Margin | 12.75 |
| Price to Book Value | 7.62 |
AI-Generated Analysis
📈 Influx Healthtech IPO is a book-built issue of ₹58.57 Cr, comprising a fresh issue of 50 lakh shares worth ₹48.00 Cr and an Offer for Sale (OFS) of 11 lakh shares aggregating ₹10.56 Cr.
📅 IPO Subscription Window:
🟢 Opens: June 18, 2025
🔴 Closes: June 20, 2025
📦 Allotment: June 23, 2025
📊 Listing: June 25, 2025 on NSE SME
💸 Price Band: ₹91 to ₹96 per share
🪙 Minimum Lot Size: 1,200 shares
👥 Retail Investment (Min): ₹1,09,200
✅ Recommended (Cutoff Price): ₹1,15,200
👤 HNI Min Investment (2 lots): ₹2,30,400
🧩 Lead Manager: Incred Capital Wealth
🧾 Registrar: KFin Technologies
🏪 Market Maker: As per SME norms
🏭 Business Model Strength:
Influx Healthtech is a rising Contract Development and Manufacturing Organization (CDMO) offering end-to-end solutions in Nutraceuticals, Ayurvedic, Cosmetics, Veterinary, and Homecare segments. It enables brands to focus on marketing while it handles formulation, production, and compliance.
🧪 Product Portfolio Includes:
💊 Tablets, Capsules, Gummies, Powders
🧴 Cosmetics: Skincare, Haircare, Soaps
🌿 Ayurvedic / Herbal Products
🐾 Veterinary Feed Supplements
🏠 Homecare Solutions
🏢 Facilities:
Located in Thane, Maharashtra, with 3 manufacturing units spanning 36,676 sq. ft, certified with WHO-GMP, ISO 22000, HACCP, and Halal standards.
👥 Workforce: 163 permanent employees as of June 2025
🤝 Major Clients:
Bling Brands Pvt Ltd
Bigflex Lifescience
Evoq Business Ventures LLP
HSHS Nutraceuticals Ltd
Bruder Life Science
🌟 Competitive Advantages:
✅ Diversified Product Portfolio
✅ End-to-End CDMO Capabilities
✅ High Compliance & Quality Standards
✅ Strong & Experienced Management Team
✅ Diverse Clientele Across Industries
Objects of the Issue – Influx Healthtech IPO
| S.No. | Objective | Amount (₹ Cr) |
|---|---|---|
| 1 | 1️⃣ 🏭 Setting Up Nutraceutical Manufacturing Facility | ₹22.60 Cr |
| 2 | 2️⃣ 🐾 Establishing Veterinary Food Division Plant | ₹11.59 Cr |
| 3 | 3️⃣ ⚙️ Machinery Purchase for Homecare & Cosmetic Division | ₹2.76 Cr |
| 4 | 4️⃣ 📄 General Corporate Purposes – [Undisclosed] |